A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation
Pengfei Xu(Henan University of Technology), Miao Wang(Zhejiang Chinese Medical University), Sandra Konrath(Universität Hamburg), Junyan Guo(Zhejiang Normal University), Nailin Li(Karolinska University Hospital), Bingyang Ji(Chinese Academy of Medical Sciences & Peking Union Medical College), De‐Pei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Haojie Rao(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhao Cui(King University), Peng Zhou(Southwest University), Huihui Li(Shanghai Medical College of Fudan University), Hong Chen(First People's Hospital of Chongqing), Jianwei Wang(Zhejiang Cancer Hospital), Jian Lin(Peking University), Liming Cai(Wuxi Fourth People's Hospital), Yingjie Zhang(Sichuan Agricultural University), Thomas Renné(Karolinska University Hospital)
Cited by 22
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k